Concepedia

Guy Van den Abeele

GV

Statistics

Publications

6

Citations

954

H-Index

6

Active since

1993

Affiliations

Alexion Pharmaceuticals (United States)(Current)

International University of Health and Welfare

National Hospital Organization Hanamaki Hospital

Alnylam Pharmaceuticals (United States)

University of North Carolina at Chapel Hill

Guy Van den Abeele is an author at Alexion Pharmaceuticals (United States) specializing in medicine, cognitive function, and geriatrics.

Top concepts

Publications per year

1993–2020

6

Publications

6

Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

James F. Howard, Kimiaki Utsugisawa, Michael Benatar et al. · The Lancet Neurology · 2017 · 745 citations

, , +3

Post-intervention Status in Patients With Refractory Myasthenia Gravis Treated With Eculizumab During REGAIN and Its Open-Label Extension

Renato Mantegazza, Gil I. Wolfe, Srikanth Muppidi et al. · Neurology · 2020 · 74 citations · Full text

European Pentoxifylline Multi-Infarct Dementia Study

Kōtaro Ōizumi, Pierre Baumann, Pertti Siira et al. · European Neurology · 1996 · 68 citations

, , +17

Response to eculizumab in patients with myasthenia gravis recently treated with chronic IVIg: a subgroup analysis of REGAIN and its open-label extension study

Saiju Jacob, Hiroyuki Murai, Kimiaki Utsugisawa et al. · Therapeutic Advances in Neurological Disorders · 2020 · 26 citations · Full text

Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

Hiroyuki Murai, Akiyuki Uzawa, Yasushi Suzuki et al. · Journal of the Neurological Sciences · 2019 · 23 citations · Full text

1–5 of 6